APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amlodipine Besylate Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amlodipine Besylate Tablets Industry Growth and Trends Forecast to 2032

2 January 2026102 pages

Choose your research edition.

Industry ResearchAmlodipine Besylate Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Amlodipine Besylate Tablets Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Amlodipine Besylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amlodipine Besylate Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Amlodipine Besylate Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Amlodipine Besylate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amlodipine Besylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amlodipine Besylate Tablets include AstraZeneca, Bristol-Myers Squibb, North China Pharmaceutical, China Resources Double-Crane Pharmaceutical, Pfizer, Jingfeng Pharmaceutical, Roche, Sanofi and Shanghai Shyndec Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amlodipine Besylate Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amlodipine Besylate Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amlodipine Besylate Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amlodipine Besylate Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amlodipine Besylate Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amlodipine Besylate Tablets Market by Company

AstraZeneca

Bristol-Myers Squibb

North China Pharmaceutical

China Resources Double-Crane Pharmaceutical

Pfizer

Jingfeng Pharmaceutical

Roche

Sanofi

Shanghai Shyndec Pharmaceutical

Yangtze River Pharmaceutical

Amlodipine Besylate Tablets Segment by Type

5 Milligrams

10 Milligrams

Amlodipine Besylate Tablets Segment by Application

Hospital

Pharmacy

Amlodipine Besylate Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amlodipine Besylate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amlodipine Besylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5 Milligrams Table 2. Major Company of 10 Milligrams Table 3. Global Amlodipine Besylate Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Amlodipine Besylate Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Amlodipine Besylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Amlodipine Besylate Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Amlodipine Besylate Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Amlodipine Besylate Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Amlodipine Besylate Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Amlodipine Besylate Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Amlodipine Besylate Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Amlodipine Besylate Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Amlodipine Besylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Amlodipine Besylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Amlodipine Besylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Amlodipine Besylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Amlodipine Besylate Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Amlodipine Besylate Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Amlodipine Besylate Tablets Industry Trends Table 25. Amlodipine Besylate Tablets Industry Drivers Table 26. Amlodipine Besylate Tablets Industry Opportunities and Challenges Table 27. Amlodipine Besylate Tablets Industry Restraints Table 28. Global Amlodipine Besylate Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Amlodipine Besylate Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Amlodipine Besylate Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Amlodipine Besylate Tablets Sales Share by Company (2021-2026) Table 32. Global Amlodipine Besylate Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Amlodipine Besylate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Amlodipine Besylate Tablets Major Company Production Sites and Headquarters Table 35. Global Amlodipine Besylate Tablets Company, Product Type & Application Table 36. Global Amlodipine Besylate Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Amlodipine Besylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Amlodipine Besylate Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Amlodipine Besylate Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Amlodipine Besylate Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Amlodipine Besylate Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Amlodipine Besylate Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Amlodipine Besylate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Amlodipine Besylate Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Amlodipine Besylate Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Amlodipine Besylate Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Amlodipine Besylate Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Amlodipine Besylate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Amlodipine Besylate Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Amlodipine Besylate Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Amlodipine Besylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Amlodipine Besylate Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Amlodipine Besylate Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Amlodipine Besylate Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Amlodipine Besylate Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Amlodipine Besylate Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Amlodipine Besylate Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Amlodipine Besylate Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Amlodipine Besylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Amlodipine Besylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Amlodipine Besylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Amlodipine Besylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Amlodipine Besylate Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Amlodipine Besylate Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca Amlodipine Besylate Tablets Product Portfolio Table 75. AstraZeneca Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. North China Pharmaceutical Company Information Table 82. North China Pharmaceutical Business Overview Table 83. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 85. North China Pharmaceutical Recent Development Table 86. China Resources Double-Crane Pharmaceutical Company Information Table 87. China Resources Double-Crane Pharmaceutical Business Overview Table 88. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 90. China Resources Double-Crane Pharmaceutical Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Amlodipine Besylate Tablets Product Portfolio Table 95. Pfizer Recent Development Table 96. Jingfeng Pharmaceutical Company Information Table 97. Jingfeng Pharmaceutical Business Overview Table 98. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 100. Jingfeng Pharmaceutical Recent Development Table 101. Roche Company Information Table 102. Roche Business Overview Table 103. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Roche Amlodipine Besylate Tablets Product Portfolio Table 105. Roche Recent Development Table 106. Sanofi Company Information Table 107. Sanofi Business Overview Table 108. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sanofi Amlodipine Besylate Tablets Product Portfolio Table 110. Sanofi Recent Development Table 111. Shanghai Shyndec Pharmaceutical Company Information Table 112. Shanghai Shyndec Pharmaceutical Business Overview Table 113. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 115. Shanghai Shyndec Pharmaceutical Recent Development Table 116. Yangtze River Pharmaceutical Company Information Table 117. Yangtze River Pharmaceutical Business Overview Table 118. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio Table 120. Yangtze River Pharmaceutical Recent Development Table 121. North America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 123. North America Amlodipine Besylate Tablets Sales Market Share by Country (2021-2026) Table 124. North America Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Amlodipine Besylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. North America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Amlodipine Besylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Amlodipine Besylate Tablets Market Share by Country (2021-2026) Table 129. North America Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Amlodipine Besylate Tablets Market Share Forecast by Country (2027-2032) Table 131. Europe Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 133. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2021-2026) Table 134. Europe Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Amlodipine Besylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Amlodipine Besylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Amlodipine Besylate Tablets Market Share by Country (2021-2026) Table 139. Europe Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Amlodipine Besylate Tablets Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Amlodipine Besylate Tablets Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Amlodipine Besylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Amlodipine Besylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Amlodipine Besylate Tablets Market Share by Country (2021-2026) Table 149. Asia-Pacific Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Amlodipine Besylate Tablets Market Share Forecast by Country (2027-2032) Table 151. Latin America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 153. Latin America Amlodipine Besylate Tablets Sales Market Share by Country (2021-2026) Table 154. Latin America Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Amlodipine Besylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Amlodipine Besylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Amlodipine Besylate Tablets Market Share by Country (2021-2026) Table 159. Latin America Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Amlodipine Besylate Tablets Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Amlodipine Besylate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Amlodipine Besylate Tablets Market Share by Country (2021-2026) Table 169. Middle East and Africa Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Amlodipine Besylate Tablets Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Amlodipine Besylate Tablets Distributors List Table 174. Amlodipine Besylate Tablets Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Amlodipine Besylate Tablets Image Figure 2. Global Amlodipine Besylate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amlodipine Besylate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Amlodipine Besylate Tablets Sales (2021-2032) & (K Units) Figure 5. 5 Milligrams Image Figure 6. Global 5 Milligrams Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10 Milligrams Image Figure 8. Global 10 Milligrams Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Amlodipine Besylate Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Amlodipine Besylate Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Amlodipine Besylate Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Amlodipine Besylate Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Amlodipine Besylate Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Amlodipine Besylate Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Amlodipine Besylate Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Amlodipine Besylate Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Amlodipine Besylate Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Amlodipine Besylate Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Amlodipine Besylate Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Amlodipine Besylate Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Amlodipine Besylate Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Amlodipine Besylate Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Amlodipine Besylate Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Amlodipine Besylate Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Amlodipine Besylate Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Amlodipine Besylate Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Amlodipine Besylate Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Amlodipine Besylate Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Amlodipine Besylate Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Amlodipine Besylate Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Amlodipine Besylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Amlodipine Besylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Amlodipine Besylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Amlodipine Besylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Amlodipine Besylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Amlodipine Besylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Amlodipine Besylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Amlodipine Besylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Amlodipine Besylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Amlodipine Besylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Amlodipine Besylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Amlodipine Besylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Amlodipine Besylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Amlodipine Besylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Amlodipine Besylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Amlodipine Besylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Amlodipine Besylate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Amlodipine Besylate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Amlodipine Besylate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Amlodipine Besylate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Amlodipine Besylate Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Amlodipine Besylate Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 5 Milligrams
  • 10 Milligrams
Applications
  • Hospital
  • Pharmacy
Companies covered
  • AstraZeneca
  • Bristol-Myers Squibb
  • North China Pharmaceutical
  • China Resources Double-Crane Pharmaceutical
  • Pfizer
  • Jingfeng Pharmaceutical
  • Roche
  • Sanofi
  • Shanghai Shyndec Pharmaceutical
  • Yangtze River Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amlodipine Besylate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amlodipine Besylate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amlodipine Besylate Tablets Market by Type
  6. 1.3.1 5 Milligrams
  7. 1.3.2 10 Milligrams
  8. 1.4 Global Amlodipine Besylate Tablets Market Size by Type
  9. 1.4.1 Global Amlodipine Besylate Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Amlodipine Besylate Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Amlodipine Besylate Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Amlodipine Besylate Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Amlodipine Besylate Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Amlodipine Besylate Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Amlodipine Besylate Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Amlodipine Besylate Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amlodipine Besylate Tablets Industry Trends
  2. 2.2 Amlodipine Besylate Tablets Industry Drivers
  3. 2.3 Amlodipine Besylate Tablets Industry Opportunities and Challenges
  4. 2.4 Amlodipine Besylate Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amlodipine Besylate Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Amlodipine Besylate Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Amlodipine Besylate Tablets Price (2021-2026)
  4. 3.4 Global Amlodipine Besylate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amlodipine Besylate Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Amlodipine Besylate Tablets Company, Product Type & Application
  7. 3.7 Global Amlodipine Besylate Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amlodipine Besylate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amlodipine Besylate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amlodipine Besylate Tablets Tier 1, Tier 2, and Tier 3
4 Amlodipine Besylate Tablets Regional Status and Outlook
  1. 4.1 Global Amlodipine Besylate Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amlodipine Besylate Tablets Historic Market Size by Region
  3. 4.2.1 Global Amlodipine Besylate Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amlodipine Besylate Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amlodipine Besylate Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amlodipine Besylate Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Amlodipine Besylate Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amlodipine Besylate Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amlodipine Besylate Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amlodipine Besylate Tablets by Application
  1. 5.1 Amlodipine Besylate Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Amlodipine Besylate Tablets Market Size by Application
  5. 5.2.1 Global Amlodipine Besylate Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Amlodipine Besylate Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Amlodipine Besylate Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Amlodipine Besylate Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Amlodipine Besylate Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Amlodipine Besylate Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Amlodipine Besylate Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Amlodipine Besylate Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Amlodipine Besylate Tablets Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 North China Pharmaceutical
  14. 6.3.1 North China Pharmaceutical Company Information
  15. 6.3.2 North China Pharmaceutical Business Overview
  16. 6.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  18. 6.3.5 North China Pharmaceutical Recent Developments
  19. 6.4 China Resources Double-Crane Pharmaceutical
  20. 6.4.1 China Resources Double-Crane Pharmaceutical Company Information
  21. 6.4.2 China Resources Double-Crane Pharmaceutical Business Overview
  22. 6.4.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  24. 6.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Amlodipine Besylate Tablets Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Jingfeng Pharmaceutical
  32. 6.6.1 Jingfeng Pharmaceutical Company Information
  33. 6.6.2 Jingfeng Pharmaceutical Business Overview
  34. 6.6.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  36. 6.6.5 Jingfeng Pharmaceutical Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Roche Amlodipine Besylate Tablets Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Sanofi
  44. 6.8.1 Sanofi Company Information
  45. 6.8.2 Sanofi Business Overview
  46. 6.8.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Amlodipine Besylate Tablets Product Portfolio
  48. 6.8.5 Sanofi Recent Developments
  49. 6.9 Shanghai Shyndec Pharmaceutical
  50. 6.9.1 Shanghai Shyndec Pharmaceutical Company Information
  51. 6.9.2 Shanghai Shyndec Pharmaceutical Business Overview
  52. 6.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  54. 6.9.5 Shanghai Shyndec Pharmaceutical Recent Developments
  55. 6.10 Yangtze River Pharmaceutical
  56. 6.10.1 Yangtze River Pharmaceutical Company Information
  57. 6.10.2 Yangtze River Pharmaceutical Business Overview
  58. 6.10.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolio
  60. 6.10.5 Yangtze River Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Amlodipine Besylate Tablets Sales by Country
  2. 7.1.1 North America Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amlodipine Besylate Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amlodipine Besylate Tablets Market Size by Country
  6. 7.2.1 North America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amlodipine Besylate Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amlodipine Besylate Tablets Sales by Country
  2. 8.1.1 Europe Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amlodipine Besylate Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amlodipine Besylate Tablets Market Size by Country
  6. 8.2.1 Europe Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amlodipine Besylate Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amlodipine Besylate Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amlodipine Besylate Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amlodipine Besylate Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amlodipine Besylate Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amlodipine Besylate Tablets Sales by Country
  2. 10.1.1 South America Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amlodipine Besylate Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amlodipine Besylate Tablets Market Size by Country
  6. 10.2.1 South America Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amlodipine Besylate Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amlodipine Besylate Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Amlodipine Besylate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amlodipine Besylate Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amlodipine Besylate Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amlodipine Besylate Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Amlodipine Besylate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amlodipine Besylate Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amlodipine Besylate Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amlodipine Besylate Tablets Value Chain Analysis
  2. 12.1.1 Amlodipine Besylate Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amlodipine Besylate Tablets Production Mode & Process
  7. 12.2 Amlodipine Besylate Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amlodipine Besylate Tablets Distributors
  10. 12.2.3 Amlodipine Besylate Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst